A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
NCT04811196
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Soft Tissue Sarcoma
Malignant Peripheral Nerve Sheath Tumor (MPNST)
Leiomyosarcoma
Endometrial Stromal Sarcoma
Interventions
DRUG:
Selinexor
Sponsor
University Health Network, Toronto